TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 1.26E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 1.59E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 2.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.98E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 3.98E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: 1.58E+4nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5(Homo sapiens (Human))
Xinthera
US Patent
Xinthera
US Patent
Affinity DataIC50: >3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair